Newswise — Waltham February 8, 2024 — For patients undergoing total hip arthroplasty (THA), the use of robotic-assisted surgery and surgical navigation techniques is not associated with an increased risk of periprosthetic joint infection (PJI), suggests a study in TheJournal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer. 

Computer navigation (CN) and robotic assistance (RA) do not alter the risk of PJI after total hip replacement surgery, according to the new research by Alberto V. Carli, MD, and colleagues of Hospital for Special Surgery, New York. 

Could CN and RA increase risks during hip replacement? 

Computer navigation and robotic assistance are increasingly used during THA. These technologies have shown beneficial effects, including more accurate component positioning and a lower risk of postoperative instability. However, "[I]t remains unknown as to whether use of [CN and RA] leads to an improvement in long-term functional outcomes or implant longevity," according to the authors.  

The use of CN and RA requires the presence of additional equipment and personnel in the operating room, and has been linked to longer operating times. Together, these factors might lead to an increased risk of surgical-site contamination and PJI, a major cause of implant failure after THA. 

Dr. Carli and colleagues analyzed their hospital's experience of nearly 13,000 patients undergoing primary THA between 2018 and 2021. During this time, CN was used during THA in 21% of patients and RA in 16%. The remaining 63% of patients underwent conventional THA without CN or RA. 

Similarly low rates of PJI, with or without new technologies 

Using a technique called propensity-score matching, the researchers identified groups of patients with similar risk factors undergoing THA by conventional methods or with the use of RA (2,003 patients in each group) or CN (2,664 patients in each group). Ninety-day rates of PJI were compared between groups, with adjustment for other factors. 

Both technologies were associated with small increases in operative times, compared to conventional THA: two minutes longer with CN and 11 minutes longer with RA. Previous studies have raised concerns that longer surgical times might lead to increased risk of complications.   

However, in the new study, the incidence of PJI was similar among groups: 0.4% for both CN and RA compared with rates of 0.2% and 0.4% for the respective propensity-matched conventional THA cohorts. In adjusted analyses, there were no significant differences in PJI risk.  

“Although computer navigation and robotic assistance are currently used in a minority of THA procedures, the increase in the use of such technology appears to be inevitable in the coming decades," the researchers write. Their study adds new evidence that, in matched groups of patients with similar characteristics, the risks of PJI are comparable, with or without the use of CN or RA. 

The authors point out some limitations of the study – notably including the overall low rate of PJI at their specialized, high-volume orthopaedic surgery center. Dr. Carli and coauthors conclude: "While the long-term clinical, functional, and implant-longevity outcomes associated with the use of computer navigation or robotic assistance remain to be elucidated, the findings of the present study are reassuring with respect to the risk of infection." 

Read Article [ Robotics and Navigation Do Not Affect the Risk of Periprosthetic Joint Infection Following Primary Total Hip Arthroplasty ] 

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit 


About The Journal of Bone & Joint Surgery 

The Journal of Bone & Joint Surgery (JBJS) has been the most valued source of information for orthopaedic surgeons and researchers for over 125 years and is the gold standard in peer-reviewed scientific information in the field. A core journal and essential reading for general as well as specialist orthopaedic surgeons worldwide, The Journal publishes evidence-based research to enhance the quality of care for orthopaedic patients. Standards of excellence and high quality are maintained in everything we do, from the science of the content published to the customer service we provide. JBJS is an independent, non-profit journal.  

About Wolters Kluwer 

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software, and services for professionals in healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.  

Wolters Kluwer reported 2022 annual revenues of €5.5 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,900 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.  

For more information, visit, follow us on LinkedIn, Facebook, and YouTube. 

Journal Link: Wolters Kluwer